Definition & Purpose of Investigator-initiated, FDA-regulated Clinical Investigations
Investigator-initiated, FDA-regulated clinical investigations occur when a Principal Investigator (PI) at Boston University/Boston Medical Center initiates a study regulated by the FDA and assumes responsibility as the Sponsor-investigator. Such investigations necessitate a thorough understanding of FDA regulations concerning test articles and require the PI to maintain comprehensive documentation throughout the investigation. These investigations are crucial for exploring novel treatments, drugs, or medical devices under regulated conditions to ensure safety and efficacy.
Steps to Complete the Form
Completing the Investigator-initiated, FDA-regulated Clinical Investigations form at BUMC requires meticulous attention to detail.
-
Initiate the FDA Application Process: The PI must submit an Investigational New Drug (IND) or Investigational Device Exemption (IDE) application to the FDA if applicable.
-
Arrange Contracts and Agreements: Contracts with collaborators and sponsors must be formalized, ensuring all legal and financial matters are addressed.
-
Ensure Compliance with Regulatory Requirements: Review and comply with all relevant federal regulations, including Good Clinical Practice (GCP) guidelines.
-
Maintain Proper Documentation: Keep detailed records of all aspects of the clinical investigation, including data collection, informed consent forms, and safety reports.
-
Submit Necessary Approvals: Obtain required approvals from Institutional Review Boards (IRBs) and other regulatory bodies before commencement.
Important Terms Related to the Form
Understanding key terms is crucial for effectively managing FDA-regulated clinical investigations.
-
Sponsor-investigator: Individual who initiates and conducts an investigation, ensuring responsibility for regulatory compliance.
-
IND Application: Investigational New Drug application required for studies involving new drugs not yet approved by the FDA.
-
IDE Application: Investigational Device Exemption required for studies involving medical devices that have not been cleared for marketing in the United States.
-
Good Clinical Practice (GCP): International ethical and scientific quality standard for conducting clinical trials involving the participation of human subjects.
Legal Use and Compliance
Legal use of Investigator-initiated, FDA-regulated Clinical Investigations involves adherence to various laws and guidelines to protect human subjects and ensure compliance.
-
FDA Regulations: Follow all applicable FDA regulations, including those concerning human subject protection and financial disclosures.
-
Informed Consent: Ensure that all subjects provide informed consent, fully understanding the nature and risks of the investigation.
-
Reporting Obligations: Regularly report to IRBs, the FDA, and other monitoring entities about the progress and any adverse events during the trial.
Key Elements of the Form
Several elements are essential when dealing with Investigator-initiated, FDA-regulated Clinical Investigations.
-
Protocol Development: Develop a detailed study protocol outlining objectives, methodology, statistical considerations, and organization.
-
Monitoring and Auditing Plans: Implement plans to ensure ongoing verification that data reported is accurate and that the investigation is conducted according to the protocol.
-
Safety Reporting: Establish mechanisms for reporting serious adverse events promptly to relevant authorities.
Eligibility Criteria for Investigators
Determining eligibility for conducting FDA-regulated clinical investigations involves several criteria:
-
Qualifications: The PI must possess the necessary educational background and experience related to the proposed investigation.
-
Resource Availability: Adequate resources, including personnel and facility capabilities, must be available to conduct the investigation.
-
Financial Disclosure: Investigators must disclose any financial interests that could impact the study to avoid conflicts of interest.
Application Process and Approval Time
The application process to conduct an investigator-initiated clinical trial involves several steps and can take several months for approval.
-
Submit a Comprehensive Application: Include all necessary documentation, such as research protocols, informed consent forms, and financial disclosures.
-
Await Regulatory Review: The FDA reviews the application for completeness and compliance. Additional information may be requested.
-
Approval and Commencement: Upon approval, the PI may begin the study, strictly adhering to the submitted protocol and regulatory guidelines.
Examples of Use in Practice
Practical examples illustrate the broad application and impact of these investigations.
-
Rare Disease Research: A PI may explore the effects of a new drug on an understudied rare disease, contributing significant insights despite limited available treatment options.
-
Device Innovation: Developing a groundbreaking medical device that requires an IDE can transform healthcare delivery, improving outcomes and achieving regulatory approval.
-
Multi-Center Trials: Collaborating across institutions on complex trials can lead to consensus on clinical practices and innovative treatment approaches.
State-Specific Rules and Considerations
While federal guidelines provide a framework, state-specific rules may also apply.
-
State Health Departments: Some states have additional regulations or ethical guidelines that need attention when conducting clinical investigations.
-
Licensing Requirements: Investigators must be licensed to practice in the state where the investigation is conducted, ensuring compliance with state professional standards.
By understanding these extensive details, researchers and legal teams can navigate the intricate landscape of conducting FDA-regulated clinical investigations effectively.
